Zymvol
Reliable Enzyme Innovation
Barcelona, Spain · Founded 2017 · $3.3M raised
- Headquarters
- Barcelona
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- zymvol.com
- Total Funding
- $3.3M
- Last Round
- $3.3M SeedFeb 2025
- Rounds
- 1
About
Zymvol Biomodeling is a Barcelona-based biotech company founded in 2017 that uses bioinformatics, molecular modelling, and AI to accelerate enzyme discovery and engineering for industrial applications. Its mission is to make custom-made enzymes accessible for any industry, turning green chemistry into the default option for manufacturers worldwide. Zymvol's computational platform can evaluate enzymatic routes across 15-20 molecules simultaneously and reduce enzyme discovery timelines from 18 months to as few as 6 months. The company is ISO 9001 and ISO 27001 certified, backed by EU funding and investors including Elaia Partners, and has delivered enzymes to customers in pharma, specialty chemicals, and sustainable materials sectors.
Summary
Zymvol is a Biotech company based in Barcelona, Spain, founded in 2017. It has raised $3.3M in total across 1 round, most recently a $3.3M Seed round in Feb 2025. Investors include Faber Ventures, Elaia and Übermorgen.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2025
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.